Review



glp 1r antagonist 1  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress glp 1r antagonist 1
    Glp 1r Antagonist 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glp+1r+antagonist+1/GLP-1R+Antagonist+1/pm41963534-51-1-11
    Average 94 stars, based on 7 article reviews
    glp 1r antagonist 1 - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: GLP-1 in the Hypothalamic Paraventricular Nucleus Promotes Sympathetic Activation and Hypertension
    Article Snippet: .. Recombinant humanGLP-1 (rhGLP-1), GLP-1R antagonist 1, SQ22536, db-cAMP, and H89 were purchased from MedChemExpress. .. Tempol, apocynin, and N-acetylcysteine (NAC) were obtained from Sigma-Aldrich.



    Similar Products

    glp 1r antagonist 1  (MedChemExpress)
    94
    MedChemExpress glp 1r antagonist 1
    Glp 1r Antagonist 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glp+1r+antagonist+1/GLP-1R+Antagonist+1/pm41963534-51-1-11
    Average 94 stars, based on 1 article reviews
    glp 1r antagonist 1 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    medchemexpress llc  (MedChemExpress)
    94
    MedChemExpress medchemexpress llc
    Medchemexpress Llc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glp+1r+antagonist+1/GLP-1R+Antagonist+1/pm41327798-222-6-6
    Average 94 stars, based on 1 article reviews
    medchemexpress llc - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    compound 5d  (MedChemExpress)
    94
    MedChemExpress compound 5d
    AMPK phosphorylation is required for Ex-4-induced activation of the Gas6/Axl pathway A, WB for p-AMPK and AMPK in BMDMs treated with MD, Ex-4 <t>and</t> <t>Compound</t> <t>5D.</t> B, Densitometry analysis of p-AMPK. C, Molecular docking model of GLP-1R and AMPK. D , Co- IP for GLP-1R and AMPK. E-G , RMSD, Rg, and RMSF analyses of the GLP-1R–AMPK complex. H and I, Hydrogen bond counts and SASA of the complex. J and K, MM/GBSA energy contribution of key residues. L, FEL analysis of the complex. M, Chemical structure of BML-275. N, WB of Gas6 and p-Axl after BML-275 treatment. O and P, Densitometric quantification of Gas6 and p-Axl. Q, IF images of p-Axl (green) and Gas6 (pink) in BMDMs; scale bar = 100 μm. R , Quantification of fluorescence intensity. S, IF of IL-6 (green) and p21 (red) in BMDMs; scale bar = 100 μm. T, Quantification of IL-6 and p21. ∗, p < 0.05, ∗∗, p < 0.01, and ∗∗∗, p < 0.001.
    Compound 5d, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glp+1r+antagonist+1/GLP-1R+Antagonist+1/pmc12446625-139-32-40
    Average 94 stars, based on 1 article reviews
    compound 5d - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    compound5d  (MedChemExpress)
    94
    MedChemExpress compound5d
    AMPK phosphorylation is required for Ex-4-induced activation of the Gas6/Axl pathway A, WB for p-AMPK and AMPK in BMDMs treated with MD, Ex-4 <t>and</t> <t>Compound</t> <t>5D.</t> B, Densitometry analysis of p-AMPK. C, Molecular docking model of GLP-1R and AMPK. D , Co- IP for GLP-1R and AMPK. E-G , RMSD, Rg, and RMSF analyses of the GLP-1R–AMPK complex. H and I, Hydrogen bond counts and SASA of the complex. J and K, MM/GBSA energy contribution of key residues. L, FEL analysis of the complex. M, Chemical structure of BML-275. N, WB of Gas6 and p-Axl after BML-275 treatment. O and P, Densitometric quantification of Gas6 and p-Axl. Q, IF images of p-Axl (green) and Gas6 (pink) in BMDMs; scale bar = 100 μm. R , Quantification of fluorescence intensity. S, IF of IL-6 (green) and p21 (red) in BMDMs; scale bar = 100 μm. T, Quantification of IL-6 and p21. ∗, p < 0.05, ∗∗, p < 0.01, and ∗∗∗, p < 0.001.
    Compound5d, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glp+1r+antagonist+1/GLP-1R+Antagonist+1/pm39266553-213-8-9
    Average 94 stars, based on 1 article reviews
    compound5d - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    il 1 receptor il 1r antagonist  (MedChemExpress)
    90
    MedChemExpress il 1 receptor il 1r antagonist
    AMPK phosphorylation is required for Ex-4-induced activation of the Gas6/Axl pathway A, WB for p-AMPK and AMPK in BMDMs treated with MD, Ex-4 <t>and</t> <t>Compound</t> <t>5D.</t> B, Densitometry analysis of p-AMPK. C, Molecular docking model of GLP-1R and AMPK. D , Co- IP for GLP-1R and AMPK. E-G , RMSD, Rg, and RMSF analyses of the GLP-1R–AMPK complex. H and I, Hydrogen bond counts and SASA of the complex. J and K, MM/GBSA energy contribution of key residues. L, FEL analysis of the complex. M, Chemical structure of BML-275. N, WB of Gas6 and p-Axl after BML-275 treatment. O and P, Densitometric quantification of Gas6 and p-Axl. Q, IF images of p-Axl (green) and Gas6 (pink) in BMDMs; scale bar = 100 μm. R , Quantification of fluorescence intensity. S, IF of IL-6 (green) and p21 (red) in BMDMs; scale bar = 100 μm. T, Quantification of IL-6 and p21. ∗, p < 0.05, ∗∗, p < 0.01, and ∗∗∗, p < 0.001.
    Il 1 Receptor Il 1r Antagonist, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/glp+1r+antagonist+1/GLP-1+receptor+agonist+2/pmc11074170-163-19-27
    Average 90 stars, based on 1 article reviews
    il 1 receptor il 1r antagonist - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    AMPK phosphorylation is required for Ex-4-induced activation of the Gas6/Axl pathway A, WB for p-AMPK and AMPK in BMDMs treated with MD, Ex-4 and Compound 5D. B, Densitometry analysis of p-AMPK. C, Molecular docking model of GLP-1R and AMPK. D , Co- IP for GLP-1R and AMPK. E-G , RMSD, Rg, and RMSF analyses of the GLP-1R–AMPK complex. H and I, Hydrogen bond counts and SASA of the complex. J and K, MM/GBSA energy contribution of key residues. L, FEL analysis of the complex. M, Chemical structure of BML-275. N, WB of Gas6 and p-Axl after BML-275 treatment. O and P, Densitometric quantification of Gas6 and p-Axl. Q, IF images of p-Axl (green) and Gas6 (pink) in BMDMs; scale bar = 100 μm. R , Quantification of fluorescence intensity. S, IF of IL-6 (green) and p21 (red) in BMDMs; scale bar = 100 μm. T, Quantification of IL-6 and p21. ∗, p < 0.05, ∗∗, p < 0.01, and ∗∗∗, p < 0.001.

    Journal: Redox Biology

    Article Title: GLP-1R activation restores Gas6-driven efferocytosis in senescent foamy macrophages to promote neural repair

    doi: 10.1016/j.redox.2025.103857

    Figure Lengend Snippet: AMPK phosphorylation is required for Ex-4-induced activation of the Gas6/Axl pathway A, WB for p-AMPK and AMPK in BMDMs treated with MD, Ex-4 and Compound 5D. B, Densitometry analysis of p-AMPK. C, Molecular docking model of GLP-1R and AMPK. D , Co- IP for GLP-1R and AMPK. E-G , RMSD, Rg, and RMSF analyses of the GLP-1R–AMPK complex. H and I, Hydrogen bond counts and SASA of the complex. J and K, MM/GBSA energy contribution of key residues. L, FEL analysis of the complex. M, Chemical structure of BML-275. N, WB of Gas6 and p-Axl after BML-275 treatment. O and P, Densitometric quantification of Gas6 and p-Axl. Q, IF images of p-Axl (green) and Gas6 (pink) in BMDMs; scale bar = 100 μm. R , Quantification of fluorescence intensity. S, IF of IL-6 (green) and p21 (red) in BMDMs; scale bar = 100 μm. T, Quantification of IL-6 and p21. ∗, p < 0.05, ∗∗, p < 0.01, and ∗∗∗, p < 0.001.

    Article Snippet: For functional assays, BMDMs were pretreated with either the p53-specific inhibitor Pifithrin-β (PFT-β, 10 μM for 24 h; HY-16702A, MedChemExpress), Exendin-4 (Ex-4, 100, 200, or 400 nM for 24 h; HY-13443, MedChemExpress), compound 5d (1 μM for 24 h, HY-101116, MedChemExpress), recombinant Mouse Gas6 (rGas6, 500 ng/mL for 2h; 986-GS-025/CF, R&D Systems, Minneapolis, MN, USA) or BML-275 (1 μM for 24 h; HY-13418A, MedChemExpress), followed by stimulation with MD (1 mg/mL) for 12 h.

    Techniques: Phospho-proteomics, Activation Assay, Co-Immunoprecipitation Assay, Fluorescence